Cargando…
GDF-15 and hepcidin as a therapeutic target for anemia in chronic kidney disease
BACKGROUND: Anaemia is a common presenting feature among patients with chronic kidney disease (CKD) and associated with poor clinical outcomes. We evaluated the diagnostic validity of growth differentiation factor-15 (GDF-15) and hepcidin as it is not clear if they are useful as a biomarkers of anae...
Autores principales: | Farag, Naglaa Makram, Mousa, Mahmoud, Elsayed, Eman, Ismeil, Ahlam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469522/ https://www.ncbi.nlm.nih.gov/pubmed/37649102 http://dx.doi.org/10.1186/s13052-023-01505-9 |
Ejemplares similares
-
Hepcidin and GDF-15 are potential biomarkers of iron deficiency anaemia in chronic kidney disease patients in South Africa
por: Nalado, Aishatu M., et al.
Publicado: (2020) -
GDF-15 and Hepcidin Levels in Nonanemic Patients with Impaired Glucose Tolerance
por: Yalcin, Mehmet Muhittin, et al.
Publicado: (2016) -
Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease
por: Larson, Derek S., et al.
Publicado: (2013) -
The association of hepcidin, reticulocyte hemoglobin equivalent and anemia-related indicators on anemia in chronic kidney disease
por: Gao, Zhaoli, et al.
Publicado: (2023) -
The role of hepcidin, GDF15, and mitoferrin-1 in iron metabolism of polycythemia vera and essential thrombocytosis patients
por: ALBAYRAK, Canan, et al.
Publicado: (2019)